Jančić, Snežana

Link to this page

Authority KeyName Variants
bacb10d6-6754-4a58-b4b3-19262f9d3cea
  • Jančić, Snežana (2)
Projects

Author's Bibliography

T4 Glottic carcinoma: oncological results and survival rate

Jancić, Slavisa; Zivić, Miško; Radovanović, Zoran; Miličić, Biljana; Đinđić, Nataša; Đinđić, Boris; Jančić, Snežana

(Drunpp-Sarajevo, Sarajevo, 2011)

TY  - JOUR
AU  - Jancić, Slavisa
AU  - Zivić, Miško
AU  - Radovanović, Zoran
AU  - Miličić, Biljana
AU  - Đinđić, Nataša
AU  - Đinđić, Boris
AU  - Jančić, Snežana
PY  - 2011
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1611
AB  - Objectives/Background: The best course of action in the case of T4 glottic carcinoma is chosen for each individual case. The aim of this study was to evaluate the potential prognostic factors and influence of postoperative and radical radiotherapy on the survival rate of patients suffering from T4 glottic carcinoma and to analyze the most appropriate conservative treatment for these patients. Methods: Study Design: A retrospective study (1995-2000) enrolled 63 patients with squamo-cellular glottic cancer in T4N1M0 stage, monitored for 5 years, divided into two groups: 30 postoperatively irradiated patients and 33 radically irradiated patients. Analysed variables were: age, sex, total therapeutical dose, number of fractions, dose per fraction and type of radiotherapeutical treatment. Standard therapeutical fractionation regimens were used, with daily sessions of 2-3 Gy, five times a week. Radiotherapy consisted of mega-voltage 10 MEV X-ray therapy. Log Rank test, Kaplan-Meier survival study, t-test, Pearson X2 - test and Cox regression were used in order to select the factors with independent effect. Results: Multivariate analysis demonstrated that none of the predictors, not even the type of radiation therapy, were statistically significant, with independent influence on survival. Conclusion: There is no significant difference in survival of patients with T4 glottic carcinoma among postoperatively and radically irradiated patients. Our results imply that the optimal radiotherapeutic modality for these patients is a total therapeutical dose no less than 65 Gy and daily fractionation with dose no less than 2,51Gy.
PB  - Drunpp-Sarajevo, Sarajevo
T2  - HealthMED
T1  - T4 Glottic carcinoma: oncological results and survival rate
VL  - 5
IS  - 6
SP  - 1737
EP  - 1743
UR  - https://hdl.handle.net/21.15107/rcub_smile_1611
ER  - 
@article{
author = "Jancić, Slavisa and Zivić, Miško and Radovanović, Zoran and Miličić, Biljana and Đinđić, Nataša and Đinđić, Boris and Jančić, Snežana",
year = "2011",
abstract = "Objectives/Background: The best course of action in the case of T4 glottic carcinoma is chosen for each individual case. The aim of this study was to evaluate the potential prognostic factors and influence of postoperative and radical radiotherapy on the survival rate of patients suffering from T4 glottic carcinoma and to analyze the most appropriate conservative treatment for these patients. Methods: Study Design: A retrospective study (1995-2000) enrolled 63 patients with squamo-cellular glottic cancer in T4N1M0 stage, monitored for 5 years, divided into two groups: 30 postoperatively irradiated patients and 33 radically irradiated patients. Analysed variables were: age, sex, total therapeutical dose, number of fractions, dose per fraction and type of radiotherapeutical treatment. Standard therapeutical fractionation regimens were used, with daily sessions of 2-3 Gy, five times a week. Radiotherapy consisted of mega-voltage 10 MEV X-ray therapy. Log Rank test, Kaplan-Meier survival study, t-test, Pearson X2 - test and Cox regression were used in order to select the factors with independent effect. Results: Multivariate analysis demonstrated that none of the predictors, not even the type of radiation therapy, were statistically significant, with independent influence on survival. Conclusion: There is no significant difference in survival of patients with T4 glottic carcinoma among postoperatively and radically irradiated patients. Our results imply that the optimal radiotherapeutic modality for these patients is a total therapeutical dose no less than 65 Gy and daily fractionation with dose no less than 2,51Gy.",
publisher = "Drunpp-Sarajevo, Sarajevo",
journal = "HealthMED",
title = "T4 Glottic carcinoma: oncological results and survival rate",
volume = "5",
number = "6",
pages = "1737-1743",
url = "https://hdl.handle.net/21.15107/rcub_smile_1611"
}
Jancić, S., Zivić, M., Radovanović, Z., Miličić, B., Đinđić, N., Đinđić, B.,& Jančić, S.. (2011). T4 Glottic carcinoma: oncological results and survival rate. in HealthMED
Drunpp-Sarajevo, Sarajevo., 5(6), 1737-1743.
https://hdl.handle.net/21.15107/rcub_smile_1611
Jancić S, Zivić M, Radovanović Z, Miličić B, Đinđić N, Đinđić B, Jančić S. T4 Glottic carcinoma: oncological results and survival rate. in HealthMED. 2011;5(6):1737-1743.
https://hdl.handle.net/21.15107/rcub_smile_1611 .
Jancić, Slavisa, Zivić, Miško, Radovanović, Zoran, Miličić, Biljana, Đinđić, Nataša, Đinđić, Boris, Jančić, Snežana, "T4 Glottic carcinoma: oncological results and survival rate" in HealthMED, 5, no. 6 (2011):1737-1743,
https://hdl.handle.net/21.15107/rcub_smile_1611 .

Histopathological evaluation of bone regeneration using human resorbable demineralized membrane

Tatić, Zoran; Stamatović, Novak; Bubalo, Marija; Jančić, Snežana; Račić, Alek; Miković, Nikola; Tatić, Natalija; Rakić, Mia

(Vojnomedicinska akademija - Institut za naučne informacije, Beograd, 2010)

TY  - JOUR
AU  - Tatić, Zoran
AU  - Stamatović, Novak
AU  - Bubalo, Marija
AU  - Jančić, Snežana
AU  - Račić, Alek
AU  - Miković, Nikola
AU  - Tatić, Natalija
AU  - Rakić, Mia
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1540
AB  - Background/Aim. Filling a bone defect with bone substitution materials is a therapy of choice, but the infiltration of connective tissue from the mucoperiostal flap may compromise a healing of bone substitutions with bony wall defects. Application of membrane as a barrier is indicated as a solution to this problem. The aim of this study was to show a pathohistological view of bone regeneration and the significance of human resorbable demineralized membrane (HRDM), 200 μ thick in bone regeneration regarding mandibular defects in an experiment on dogs. Methods. The experiment was performed on six dogs. Bone defects were created in all six dogs on the right side of the mandible after the elevation of the mucoperiostal flap. One defect was filled with human deproteinised bone (HDB), and in between HDB and soft tissue RHDM of 200 μ thick was placed. In the second defect, used as a control one, only HDB without RHDM was placed. Two dogs were sacrificed two months after the surgery, another two dogs four months after the surgery and the last two dogs six months after the surgery. After that, samples of bone tissue were taken for histopathological analysis. Results. In all the six dogs with defects treated with HDB and RHDM the level of bone regeneration was much higher in comparison with the control defects without RHDM. Conclusion. Membrane, as a cover of bony defect, is useful and benefits bone regeneration. Bony defects covered with RHDM show better bony healing despite the fact that bone regeneration was not fully complete for as long as six months after the RHDM implantation.
AB  - Uvod/Cilj. Popunjavanje koštanih defekata zamenicima kosti je terapija izbora, ali prorastanje vezivnog tkiva iz mukoperiostalnog režnja može kompromitovati sam proces zarastanja zamenika kosti sa zidovima koštanih defekata. U cilju rešavanja ovog problema indikovana je primena membrane kao barijere. Cilj ove studije bio je da se prikaže patohistološki izgled koštane regeneracije i značaj resorptivne demineralizovane membrane humanog porekla (RHDM), debljine 200 mikrona, u regeneraciji kosti kod mandibularnih defekata u eksperimentu rađenom na psima. Metode. Eksperiment je vršen na šest pasa kojima je sa desne strane donje vilice, po podizanju mukoperiostalnog režnja, pravljen koštani defekt. U jedan defekt stavljana je humana deproteinizovana kost (HDK), a između nje i mekotkivnog dela stavljana je RHDM debljine 200 mikrona. U drugi defekt, koji je služio kao kontrola, stavljena je samo HDK, bez RHDM. Dva psa žrtvovana su dva meseca nakon hirurške intervencije, dva posle četiri meseca, a preostala dva šest meseci nakon hirurške intervencije. Nakon žrtvovanja uzimani su isečci za patohistološku analizu. Rezultati. Kod svih šest pasa kod kojih je u koštani defekt ugrađena HDK i RHDM stepen koštane regeneracije bio je daleko veći u odnosu na kontrolne defekte bez RHDM. Zaključak. Membrana, kao pokrivač koštanog defekta, podesna je i poboljšava koštanu regeneraciju. Koštani defekti prekriveni RHDM pokazali su značajno bolje koštano zarastanje, mada koštana regeneracija nije bila potpuna ni šest meseci nakon njene ugradnje.
PB  - Vojnomedicinska akademija - Institut za naučne informacije, Beograd
T2  - Vojnosanitetski pregled
T1  - Histopathological evaluation of bone regeneration using human resorbable demineralized membrane
T1  - Uticaj resorptivne membrane humanog porekla na regeneraciju koštanog tkiva - patohistološka studija
VL  - 67
IS  - 6
SP  - 480
EP  - 486
DO  - 10.2298/VSP1006480T
ER  - 
@article{
author = "Tatić, Zoran and Stamatović, Novak and Bubalo, Marija and Jančić, Snežana and Račić, Alek and Miković, Nikola and Tatić, Natalija and Rakić, Mia",
year = "2010",
abstract = "Background/Aim. Filling a bone defect with bone substitution materials is a therapy of choice, but the infiltration of connective tissue from the mucoperiostal flap may compromise a healing of bone substitutions with bony wall defects. Application of membrane as a barrier is indicated as a solution to this problem. The aim of this study was to show a pathohistological view of bone regeneration and the significance of human resorbable demineralized membrane (HRDM), 200 μ thick in bone regeneration regarding mandibular defects in an experiment on dogs. Methods. The experiment was performed on six dogs. Bone defects were created in all six dogs on the right side of the mandible after the elevation of the mucoperiostal flap. One defect was filled with human deproteinised bone (HDB), and in between HDB and soft tissue RHDM of 200 μ thick was placed. In the second defect, used as a control one, only HDB without RHDM was placed. Two dogs were sacrificed two months after the surgery, another two dogs four months after the surgery and the last two dogs six months after the surgery. After that, samples of bone tissue were taken for histopathological analysis. Results. In all the six dogs with defects treated with HDB and RHDM the level of bone regeneration was much higher in comparison with the control defects without RHDM. Conclusion. Membrane, as a cover of bony defect, is useful and benefits bone regeneration. Bony defects covered with RHDM show better bony healing despite the fact that bone regeneration was not fully complete for as long as six months after the RHDM implantation., Uvod/Cilj. Popunjavanje koštanih defekata zamenicima kosti je terapija izbora, ali prorastanje vezivnog tkiva iz mukoperiostalnog režnja može kompromitovati sam proces zarastanja zamenika kosti sa zidovima koštanih defekata. U cilju rešavanja ovog problema indikovana je primena membrane kao barijere. Cilj ove studije bio je da se prikaže patohistološki izgled koštane regeneracije i značaj resorptivne demineralizovane membrane humanog porekla (RHDM), debljine 200 mikrona, u regeneraciji kosti kod mandibularnih defekata u eksperimentu rađenom na psima. Metode. Eksperiment je vršen na šest pasa kojima je sa desne strane donje vilice, po podizanju mukoperiostalnog režnja, pravljen koštani defekt. U jedan defekt stavljana je humana deproteinizovana kost (HDK), a između nje i mekotkivnog dela stavljana je RHDM debljine 200 mikrona. U drugi defekt, koji je služio kao kontrola, stavljena je samo HDK, bez RHDM. Dva psa žrtvovana su dva meseca nakon hirurške intervencije, dva posle četiri meseca, a preostala dva šest meseci nakon hirurške intervencije. Nakon žrtvovanja uzimani su isečci za patohistološku analizu. Rezultati. Kod svih šest pasa kod kojih je u koštani defekt ugrađena HDK i RHDM stepen koštane regeneracije bio je daleko veći u odnosu na kontrolne defekte bez RHDM. Zaključak. Membrana, kao pokrivač koštanog defekta, podesna je i poboljšava koštanu regeneraciju. Koštani defekti prekriveni RHDM pokazali su značajno bolje koštano zarastanje, mada koštana regeneracija nije bila potpuna ni šest meseci nakon njene ugradnje.",
publisher = "Vojnomedicinska akademija - Institut za naučne informacije, Beograd",
journal = "Vojnosanitetski pregled",
title = "Histopathological evaluation of bone regeneration using human resorbable demineralized membrane, Uticaj resorptivne membrane humanog porekla na regeneraciju koštanog tkiva - patohistološka studija",
volume = "67",
number = "6",
pages = "480-486",
doi = "10.2298/VSP1006480T"
}
Tatić, Z., Stamatović, N., Bubalo, M., Jančić, S., Račić, A., Miković, N., Tatić, N.,& Rakić, M.. (2010). Histopathological evaluation of bone regeneration using human resorbable demineralized membrane. in Vojnosanitetski pregled
Vojnomedicinska akademija - Institut za naučne informacije, Beograd., 67(6), 480-486.
https://doi.org/10.2298/VSP1006480T
Tatić Z, Stamatović N, Bubalo M, Jančić S, Račić A, Miković N, Tatić N, Rakić M. Histopathological evaluation of bone regeneration using human resorbable demineralized membrane. in Vojnosanitetski pregled. 2010;67(6):480-486.
doi:10.2298/VSP1006480T .
Tatić, Zoran, Stamatović, Novak, Bubalo, Marija, Jančić, Snežana, Račić, Alek, Miković, Nikola, Tatić, Natalija, Rakić, Mia, "Histopathological evaluation of bone regeneration using human resorbable demineralized membrane" in Vojnosanitetski pregled, 67, no. 6 (2010):480-486,
https://doi.org/10.2298/VSP1006480T . .
2
1
2